Royal Aust & NZ College of Obstetricians and Gynaecologists RANZCOG

Royal Aust & NZ College of Obstetricians and Gynaecologists RANZCOG Advocate for women's healthcare across AUS & NZ. Advocates on women’s health issues across Australia and New Zealand.

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) is the leading standards body responsible for the training and education of specialists and GP obstetricians in obstetrics and gynaecology in Australia and New Zealand. It is committed to the establishment and maintenance of the highest possible standards of practice in women’s health and provides programs in training, accreditation and continuing professional development (CPD) that are responsive to the evolving health care needs of women. As such, the RANZCOG:

Sets the individual curricula, training programs and assessments to ensure that those graduating have the essential attributes and key competencies expected for clinical competency and effective practice as a medical practitioner, specialist or subspecialist within the chosen scope of practice. Provides advice to Federal and jurisdictional Government committees and other organisations. Develops best practice advice on issues relating to obstetrics and gynaecology offered in a range of formats including Patient Information Pamphlets and College Statements, Clinical Practice Guidelines, Positions and Communiques. Supports and develops educational initiatives, programs and resources for health professionals in Indigenous women’s health and those in Asia and the Pacific. Provides a CPD program facilitating training, continuing education, peer review and life-long learning. Supports research and advocacy for women’s health by forging productive relationships with individuals, the community and professional organisations, both locally and internationally. RANZCOG has approximately 5,500 members in Australia and New Zealand and internationally.

14/10/2025

Cervical screening is an essential public health measure in the prevention of cervical cancer, and practice continues to evolve with new evidence and recommendations.

In this episode of Talking O&G: A RANZCOG Podcast, host Dr Nisha Khot is joined by Associate Professor Jared Watts and Dr Anna Clare to unpack RANZCOG’s new Signposting Guideline: Cervical Cancer Screening in Australia and Aotearoa New Zealand.

The conversation covers HPV screening, risk-based recommendations, providing trauma-informed and culturally safe care, practical considerations for testing in pregnancy, hysterectomy and non-sexually active patients, self-collection, and what’s next for cervical screening across Australia.

🎧 Listen or watch now via your preferred streaming platform.
https://ranzcog.edu.au/podcast/

12/10/2025

🎧 This morning, President-Elect Dr Nisha Khot joined SBS’ Headlines on Health podcast to discuss the miscarriage data gap and the importance of multidisciplinary care in supporting people experiencing pregnancy loss.

The podcast’s release coincides with the Pink Elephants Support Network’s new report, Not Just a Loss, published today. The report reviews national and global miscarriage data and highlights the urgent need for better data collection to enable Australia to develop evidence-based policies or fund services that address the systematic inequities keeping families from receiving timely, compassionate care.

Currently, there is no national data collection system in Australia or New Zealand that accurately captures the true scope of pregnancy loss. This lack of data makes it difficult to understand how many people experience miscarriage or ectopic pregnancy and can create barriers to accessing support services and improving prevention efforts.

RANZCOG supports the report’s call for the establishment of a national data collection system, as well as the provision of care that is empathetic, evidence-based, and acknowledges the significance of loss - reflecting the recommendations outlined in the College’s own clinical guideline.

Listen to the full episode via: https://www.sbs.com.au/news/podcast/headlines-on-health (link in bio)

October is Pregnancy and Infant Loss Awareness Month, a time to honour the grief and loss experienced by parents and fam...
08/10/2025

October is Pregnancy and Infant Loss Awareness Month, a time to honour the grief and loss experienced by parents and families, and to educate, and raise awareness for a reality that many endure in silence.

Early pregnancy loss affects many families across Australia and Aotearoa New Zealand. Earlier this year, RANZCOG released its updated binational clinical guideline — Miscarriage, Recurrent Miscarriage and Ectopic Pregnancy (C-Gyn 38) — to support best-practice care, with one of the key changes being an updated definition of recurrent miscarriage. Clinicians can learn more about these updates by tuning in to Episode 1 of Talking O&G: A RANZCOG Podcast, where hosts and guests unpack the key recommendations and their impact on clinical practice.

RANZCOG is also pleased to announce the release of new patient information pamphlets on miscarriage and ectopic pregnancy, designed to support women and families affected by these experiences.

Miscarriage: ranzcog.edu.au/wp-content/uploads/Miscarriage.pdf
Ectopic Pregnancy: ranzcog.edu.au/wp-content/uploads/Ectopic-Pregnancy.pdf

🚫 No publicly funded hospital should be able to deny abortion care.  RANZCOG supports the recommendations in 'Access in ...
06/10/2025

🚫 No publicly funded hospital should be able to deny abortion care.

RANZCOG supports the recommendations in 'Access in Action: Abortion Care in Victoria', released today by state crossbenchers. The Report identifies key barriers to abortion access: including affordability, accessibility, institutional or “corporate” conscientious objectors, and workforce shortages.

President-Elect Dr Nisha Khot spoke to the Herald Sun about the Report’s Recommendation 6, which advises that the Victorian Government end “corporate conscientious objection” – where an entire hospital or facility (often a publicly funded religious institution) refuses to provide reproductive care because of organisational beliefs or values.

RANZCOG has long called for an end to this practice, including in its written and verbal submissions to the Inquiry into Universal Access to Reproductive Healthcare. Despite the report identifying the ‘type of provider, including religious affiliation and the degree of conscientious objection’ as a barrier to access, federal government and state and territory health ministers only agreed in principle to the related recommendation, and are yet to make any meaningful policy changes.

When publicly funded facilities deny access to abortion care, women suffer and are often forced to either travel (sometimes hundreds of kilometers) or pay significant out-of-pocket costs for this essential, time critical care.

Abortion is essential healthcare. Healthcare decisions belong solely to women or pregnant people, and their clinician – not publicly funded institutions.

Read the report in full:https://static1.squarespace.com/static/6434da880f97cb3175ffea0b/t/68e2fdc74f21b047c9b1003e/1759706567346/AJP+%26+LCV+Abortion+Access+Report-2025+10-report+r8.pdf

Good news! A new oral contraceptive is available on the PBS from today, expanding contraceptive choices in Australia.Est...
30/09/2025

Good news! A new oral contraceptive is available on the PBS from today, expanding contraceptive choices in Australia.

Estetrol with drospirenone is amoung several new listings announced from 1 October.
Last year, RANZCOG advocated to the Pharmaceutical Benefits Advisory Committee (PBAC) in support of the adoption of a range of medications - including this one - highlighting equity and access issues, as well as the challenges caused by ongoing shortages of medicines and devices within women's health more broadly.

The College welcomes the Federal Government’s investment in expanding choice and making contraception more affordable, and reiterates its recommendation that contraception be made free in Australia, as outlined in its 2025/2026 Pre-Budget submission.

ICYMI the spring edition of O&G Magazine is now available online! In this edition, clinicians and lived-experience advoc...
25/09/2025

ICYMI the spring edition of O&G Magazine is now available online! In this edition, clinicians and lived-experience advocates alike explore the multifaceted disease that affects so many women around Australia and Aotearoa New Zealand, endometriosis.

This issue features a discussion on the release of the new "Australian Living Evidence Guideline: Endometriosis," a special lived experience Q+A feature with Bindi Irwin, & many more articles which delve into the depths of endometriosis.

Read online now at: https://www.ogmagazine.org.au/

The Trump administration has made highly controversial claims about the causes of autism and ADHD, asserting that parace...
22/09/2025

The Trump administration has made highly controversial claims about the causes of autism and ADHD, asserting that paracetamol (also known as acetaminophen) use during pregnancy increases the risk of children being diagnosed as neurodivergent.

RANZCOG joins leading clinicians and scientists worldwide in rejecting these claims. Scientific evidence shows no link between paracetamol use in pregnancy and autism or ADHD during childhood, with several large and reliable studies directly contradicting the administration’s statement.

The causes of neurodivergence are incompletely understood and remain complex, involving both genetic and environmental factors. Earlier studies raising concerns about paracetamol could not determine whether the medicine itself was responsible, or whether other factors explained the association.

A much larger and stronger study, published in 2024 by Ahlqvist and colleagues, looked at 2.5 million children in Sweden. When they accounted for important factors like family history of autism/ADHD and sibling comparisons, they found no link between paracetamol use during pregnancy and children developing autism or ADHD.

The use of medications during pregnancy should always balance the potential benefits against any potential harms - both of the medication and of the condition being treated - to the mother and the fetus. The Ahlqvist study provides conclusive evidence that paracetamol use during pregnancy does not increase the chance of neurodivergence in the offspring and therefore should be considered safe to use in pregnancy where there is a clear reason to do so.

People who are uncertain about medication use in pregnancy should discuss this with their doctor or midwife.

Learn more in a statement on the College’s website: https://ranzcog.edu.au/news/paracetamol-use-in-pregnancy/

Syphilis cases are rising sharply across Australia and Aotearoa New Zealand. While treatable once detected, syphilis fre...
19/09/2025

Syphilis cases are rising sharply across Australia and Aotearoa New Zealand.

While treatable once detected, syphilis frequently presents without symptoms – which means it can be unknowingly passed on during pregnancy, with serious risks for both mother and baby.

📈 In 2024, Australia recorded nearly 6,000 cases of infectious syphilis, including more than 1,000 cases in women aged 15–44.

🤰 During pregnancy, syphilis carries serious risks such as stillbirth, preterm birth and congenital syphilis (when the infection is passed onto the unborn baby).

RANZCOG has released updated guidance to support O&G specialists and health professionals, including best-practise recommendations for the prevention and management of syphilis during pregnancy.

The main takeaway for clinicians? Consistent, repeated testing regardless of risk and timely treatment are essential, along with effective contact tracing, specialist referral, and neonatal assessment.

🔗 Read the full guideline here: https://ranzcog.edu.au/news/syphilis-advice/

Mark Butler MP Rebecca White

It took Bindi Irwin more than ten years to be diagnosed with endometriosis. In that time, she lived with daily pain, nau...
12/09/2025

It took Bindi Irwin more than ten years to be diagnosed with endometriosis. In that time, she lived with daily pain, nausea, and fatigue – as well as the emotional toll of feeling unheard while trying her hardest to carry on.

The Spring edition of RANZCOG's O&G Magazine is dedicated to endometriosis. It features Bindi’s experience navigating delayed diagnosis, the realities of living with an invisible illness, and why listening to patients matters. She shares what helped her push for answers, how motherhood shaped her advocacy, why listening to patients matters, and what she hopes clinicians will take from her story.

📖 Read the full article in O&G Magazine – Endometriosis: www.ogmagazine.org.au/27/3-27/bindi-irwin-living-with-endometriosis/

Members and trainees, look out for your copy of O&G Magazine in your mail box from 17 September onwards!

September 10 marks International Gynaecological Awareness Day. A day created to break down stigmas, and bring awareness ...
09/09/2025

September 10 marks International Gynaecological Awareness Day. A day created to break down stigmas, and bring awareness to gyneacological conditions, such as those affecting the v***a and gynaecological cancers.

For the day's founder, Kath Mazella OAM, this day is more than just an awareness day, it's an opportunity to educate and empower people, and create change. In the most recent edition of O&G Magazine, The V***a, Kath shares her personal journey with v***ar cancer, how she connected with others going through the same thing, and how her lived-experience led her to become a passionate advocate and a voice for women and v***a-owners.

Read more about Kath's story and IGAD: www.ogmagazine.org.au/27/2-27/advocating-for-v***ar-health/

Do you have a compelling case study or unique perspective on perinatal infections? RANZCOG invites clinicians, researche...
05/09/2025

Do you have a compelling case study or unique perspective on perinatal infections? RANZCOG invites clinicians, researchers, and those with lived experience to contribute to the upcoming issue of O&G Magazine.

The College is looking for real-world insights—whether clinical, diagnostic, or lived experience—that highlight challenges, management, and approaches to care in this important area of practice.

To express your interest, please submit:
• A working title
• A short summary (100–150 words)
• Author details

EOI Deadline: 22 September
Submissions can be made via: https://www.cognitoforms.com/RANZCOG/CallForExpressionsOfInterestCaseStudiesOnPerinatalInfections

The editorial team will be in touch with selected contributors to guide next steps for full submission and peer review.

04/09/2025

This week's episode of Talking O&G: A RANZCOG Podcast explores the College's updated guideline: Substance Use in Pregnancy (C-Obs 53). Join host, Dr Kasia Siwicki, as she speaks with Dr Anna Clare, Dr Dan Wilson and Kerri Felemonow to unpack what is new in the updated guideline.

They discuss the importance of using non-stigmatising language, universal screening in antenatal care, evidence-based support and therapies for substance use in pregnancy, and much more.

🎧 Listen now or watch via your preferred streaming platform.
https://ranzcog.edu.au/podcast/

Address

1 Bowen Crescent
Melbourne, VIC
3004

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

+61394171699

Alerts

Be the first to know and let us send you an email when Royal Aust & NZ College of Obstetricians and Gynaecologists RANZCOG posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Royal Aust & NZ College of Obstetricians and Gynaecologists RANZCOG:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) is the leading standards body responsible for the training and education of specialists and GP obstetricians in obstetrics and gynaecology in Australia and New Zealand.

RANZCOG is committed to the establishment and maintenance of the highest possible standards of practice in women’s health and provides programs in training, accreditation and continuing professional development (CPD) that are responsive to the evolving healthcare needs of women.

RANZCOG supports research into women’s health and acts as an advocate for women’s healthcare by forging productive relationships with individuals, the community and professional organisations, both locally and internationally.

Our mission is to influence the standard of care delivered to our community through education and training, advocacy and policy development.